Skip to main content
LinkedIn
X
Instagram
Facebook
YouTube
Email
People
Events
News
Search site:
National Cancer Institute
Frederick National Laboratory
Menu
Mega Menu
Research & Technology
Science Areas
AIDS and Cancer Virus Program
Program Overview
Sections
Retroviral Evolution Section
Retroviral Pathogenesis Section
Retrovirus-Cell Interaction Section
Viral Oncology Section
Viral Persistence Section
Cores
Biological Products Core
Cellular Immunity Core
HIV Molecular Monitoring Core
Nonhuman Primate Research Support Core
Quantitative Molecular Diagnostics Core
Tissue Analysis and Retroviral Protein Chemistry Core
Viral Evolution Core
Basic Science Program
Program Overview
Computational Structural Biology Section
Epigenetics Section
HLA Immunogenetics Section
Molecular Immunology Section
Bioinformatics and Computational Science
Program Overview
Advanced Biomedical Computational Science
Center for Technical Operations Support
Cancer Research Technology Program
Program Overview
Advanced Cryo-Electron Microscopy Technology Group
Antibody Characterization Laboratory
Cancer Data Science Initiatives
CLIA Molecular Diagnostics Laboratory
Imaging Mass Cytometry Laboratory
Nanotechnology Characterization Laboratory
National Cryo-Electron Microscopy Facility
Protein Expression Laboratory
Laboratory Animal Sciences Program
Program Overview
Animal Diagnostics Laboratory
Animal Research Technical Support
Center for Advanced Preclinical Research
Genome Modification Core
Gnotobiotics Facility
Laboratory Animal Medicine
Molecular Histopathology Laboratory
Mouse Modeling and Cryopreservation
Small Animal Imaging Program
Vaccine, Immunity, and Cancer Directorate
Program Overview
Cancer Immunoprevention Laboratory
Center of Excellence for Serology Development and Emergency Preparedness
HPV and COVID-19 Serology Laboratories
SeroNet Coordinating Center
New CRISPR screening platform could drive development of next-generation drugs
Arrow Icon
Clinical Trial Support
Applied and Developmental Research Directorate
Program Overview
Clinical Services Program
AIDS Monitoring Laboratory
Bioprocessing Laboratory
Blood Processing Core
Clinical Support Laboratory
Flow Cytometry Support Laboratory
Immunological Monitoring Laboratory
Laboratory of Human Retrovirology and Immunoinformatics
Laboratory of Molecular Cell Biology
Neutrophil Monitoring Laboratory
Radiochemistry Program
Virus Isolation and Serology Laboratory
DCTD Support
Cancer Imaging Informatics Laboratory
Clinical Pharmacodynamics - Biomarkers Program
In Vitro Evaluation and Molecular Pharmacology Laboratories
In Vivo Evaluation Program
Investigative Toxicology Laboratory
NExT Chemical Biology Consortium Support Programs
Natural Products Support Group
Pharmacokinetics and Drug Analysis Group
Radiochemistry Support Group
Biopharmaceutical Development Program
Clinical Monitoring Research Program
Clinical Research Directorate
Program Overview
Biospecimen Research Group
Cancer Genomics Research Laboratory
Drug Discovery and Development Program
Molecular Characterization Laboratory
Vaccine Clinical Materials Program
‘Last Mile’ Initiative SHIP Trial
Clinical Monitoring Research Program to support clinical study exploring alternative to cervical cancer screening
A new U.S. clinical trial will evaluate whether an at-home, self-collection technique to screen for cervical cancer is as accurate and effective as a Pap smear test done in a healthcare clinic.
Innovation & Initiatives
Initiatives
RAS Initiative
Scientific Standards Hub
SeroNet
Newsletter
Spring 2024 SeroNews
Latest edition of SeroNews highlights viral evolution.
Innovation
Center for Innovation and Strategic Partnerships
Patents
Importance of innovation
Within FNL, innovation plays a pivotal role in delivering new and enhanced technologies that empower us to tackle essential scientific inquiries, enhance our services, and ultimately contribute to the wellbeing of patients.
Vladimir Popov, Ph.D., MBA
Scientific Series
Biotech Connector
High Fidelity
Life Sciences Symposium
RAS Initiative Symposium
Scientific Partners Distinguished Lecture Series
Technology Showcase
Women in Science Speak
Scientific Partners Distinguished Lecture Series
STAG2 Mutations in the Pathogenesis of Human Cancer
Dr. Todd Waldman of Georgetown University presents this lecture.
Investigator Resources
Data & Repositories
BRB Preclinical Biologics Repository
dbGuide
NCI Mouse Repository
sgRNA Scorer
More Repositories
Did you know?
To date, the Antibody Characterization Laboratory has developed 944 antibodies to 568 antigen targets.
Training & Education
cGMP Training
NCEF Cryo-EM Training Program
Training Workshop
vEM 101: volume Electron Microscopy
This two-day workshop will offer an up-close and in-person view of sample preparation, imaging, and image processing in a leading vEM laboratory.
Technical Services
Program Overview
HIV/SIV Services
Cellular or Tissue SIV/SHIV RNA and DNA testing
HIV/SIV Single Genome Amplification and Sequencing
Lineage-specific Next Gen Multiplex In Situ Hybridization for HIV or SIV RNA and DNA
Next-generation sequencing analysis of barcoded SIV, SHIV, or HIV
Novel CD4+ T Cell Specific Immunohistochemistry Detection and Analysis
Plasma or CSF SIV/SHIV RNA measurements
Quantitative Assessment of Lymphoid Tissue Fibrosis
Quantitative assessment of HIV or SIV viral DNA in laser capture microdissected immune cells
Viral Integration Site Analysis (VISA) for HIV studies
Laboratory Animal Services
Assessment of Drug Efficacy in a Survival Study
In Vitro Cell Cytotoxicity Evaluation
Pharmacokinetic Evaluation in Kras/p53 PDAC Mice
Time Course Assessment of Tumor Response to Therapeutics
Tolerance Evaluation of Experimental Compound in Kras/p53 PDAC Mice
Use of Mouse Embryonic Stem Cells Expressing miRNAs
Nanomedicine & Nanoformulation
An in vitro drug release study in human plasma
Pharmacokinetic study of nanomedicine in rats
Other
Detection of Mycobacterium tuberculosis DNA
mRNA Isolation and Expression Analysis in Human B-cell Lymphoma Samples
Researcher Resource
Nanotechnology Characterization Laboratory
Comprehensive preclinical characterization of nanomedicine formulations.
Universal Standards & Reference Materials
AI and Data Science
Antibody Science
Biospecimen Assays
Biopharmaceutical Development
Electron Microscopy
HPV Serology Operating Procedures
Human SARS-CoV-2 Serology Standard
Nanotechnology
Protein Science
FNL Initiative
Scientific Standards Hub
Collection of scientific groups at FNL working to develop, deposit and share standards and references in biological research.
Work With Us
Collaboration
Partnership Development Office
Partnership Mechanisms
Academic Partnerships
Partnership Spotlight
In December 2023, we executed an FNL CRADA with the National Cancer Center Japan that was led by Pinyi Lu of the Cancer Research Technology Program. The purpose of this project is to develop a novel workflow integrating structure and AI-based modeling approaches to accelerate the discovery of novel CENP-E inhibitors, that prevent cancer progression.
Maggie Scully, Ph.D.
Tech Transfer & Licensing
Intellectual Property and Strategic Agreements
NCI & FNL event
2024 Technology Showcase
Technology presentations, poster sessions, and expert discussions on topics including financing, leveraging incubators and working with patient advocacy groups.
Vendors & Subcontractors
Become a Vendor
Business Opportunities
Contracts and Acquisitions
Small Businesses, Nonprofits & HBCUs
Subcontracting Spotlight
Morehouse School of Medicine biospecimens to boost diversity of cancer samples for proteogenomic analysis
Morehouse joins the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC).
Careers
Job Opportunities
Scientific openness
Here at FNL, we share our ideas, resources, time and creativity. Also, I love how there's room to have these really big ideas that wouldn’t be feasible in any other research setting.
Christine Fennessey, Ph.D.
Application Process
Benefits
Diversity and Inclusion
Internships and Fellowships
About FNL
Who We Are
Mission & Core Values
Community Outreach
People
Publications
History
Crystal Canja
HBCU/MSI Program Manager,
Partnership Development Office
Research
Science Areas
AIDS and Cancer Virus Program
Sections
Retroviral Evolution Section
Retroviral Pathogenesis Section
Retrovirus-Cell Interaction Section
Viral Oncology Section
Viral Persistence Section
Cores
Biological Products Core
Cellular Immunity Core
HIV Molecular Monitoring Core
Nonhuman Primate Research Support Core
Quantitative Molecular Diagnostics Core
Tissue Analysis and Retroviral Protein Chemistry Core
Viral Evolution Core
Basic Science Program
Computational Structural Biology Section
Epigenetics Section
HLA Immunogenetics Section
Molecular Immunology Section
Bioinformatics and Computational Science
Advanced Biomedical Computational Science
Center for Technical Operations Support
Cancer Research Technology Program
Advanced Cryo-Electron Microscopy Technology Group
Antibody Characterization Laboratory
Cancer Data Science Initiatives
CLIA Molecular Diagnostics Laboratory
Imaging Mass Cytometry Laboratory
Nanotechnology Characterization Laboratory
National Cryo-Electron Microscopy Facility
Protein Expression Laboratory
Laboratory Animal Sciences Program
Animal Diagnostics Laboratory
Animal Research Technical Support
Center for Advanced Preclinical Research
Genome Modification Core
Gnotobiotics Facility
Laboratory Animal Medicine
Molecular Histopathology Laboratory
Mouse Modeling and Cryopreservation
Small Animal Imaging Program
Vaccine, Immunity, and Cancer Directorate
Cancer Immunoprevention Laboratory
Center of Excellence for Serology Development and Emergency Preparedness
HPV and COVID-19 Serology Laboratories
SeroNet Coordinating Center
Clinical Trial Support
Applied and Developmental Research Directorate
Clinical Services Program
AIDS Monitoring Laboratory
Bioprocessing Laboratory
Blood Processing Core
Clinical Support Laboratory
Flow Cytometry Support Laboratory
Immunological Monitoring Laboratory
Laboratory of Human Retrovirology and Immunoinformatics
Laboratory of Molecular Cell Biology
Neutrophil Monitoring Laboratory
Radiochemistry Program
Virus Isolation and Serology Laboratory
DCTD Support
Cancer Imaging Informatics Laboratory
Clinical Pharmacodynamics - Biomarkers Program
In Vitro Evaluation and Molecular Pharmacology Laboratories
In Vivo Evaluation Program
Investigative Toxicology Laboratory
NExT Chemical Biology Consortium Support Programs
Natural Products Support Group
Pharmacokinetics and Drug Analysis Group
Radiochemistry Support Group
Biopharmaceutical Development Program
Clinical Monitoring Research Program
Clinical Research Directorate
Biospecimen Research Group
Cancer Genomics Research Laboratory
Drug Discovery and Development Program
Molecular Characterization Laboratory
Vaccine Clinical Materials Program
Innovation & Initiatives
Initiatives
RAS Initiative
Scientific Standards Hub
SeroNet
Innovation
Center for Innovation and Strategic Partnerships
Patents
Scientific Series
Biotech Connector
High Fidelity
Life Sciences Symposium
RAS Initiative Symposium
Scientific Partners Distinguished Lecture Series
Technology Showcase
Women in Science Speak
Resources
Data & Repositories
BRB Preclinical Biologics Repository
dbGuide
NCI Mouse Repository
sgRNA Scorer
More Repositories
Novel Technologies
Imaging
Training & Education
cGMP Training
NCEF Cryo-EM Training Program
Technical Services
Program Overview
HIV/SIV Services
Cellular or Tissue SIV/SHIV RNA and DNA testing
HIV/SIV Single Genome Amplification and Sequencing
Lineage-specific Next Gen Multiplex In Situ Hybridization for HIV or SIV RNA and DNA
Next-generation sequencing analysis of barcoded SIV, SHIV, or HIV
Novel CD4+ T Cell Specific Immunohistochemistry Detection and Analysis
Plasma or CSF SIV/SHIV RNA measurements
Quantitative Assessment of Lymphoid Tissue Fibrosis
Quantitative assessment of HIV or SIV viral DNA in laser capture microdissected immune cells
Viral Integration Site Analysis (VISA) for HIV studies
Laboratory Animal Services
Assessment of Drug Efficacy in a Survival Study
In Vitro Cell Cytotoxicity Evaluation
Pharmacokinetic Evaluation in Kras/p53 PDAC Mice
Time Course Assessment of Tumor Response to Therapeutics
Tolerance Evaluation of Experimental Compound in Kras/p53 PDAC Mice
Use of Mouse Embryonic Stem Cells Expressing miRNAs
Nanomedicine & Nanoformulation
An in vitro drug release study in human plasma
Pharmacokinetic study of nanomedicine in rats
Other
Detection of Mycobacterium tuberculosis DNA
mRNA Isolation and Expression Analysis in Human B-cell Lymphoma Samples
Universal Standards & Reference Materials
AI and Data Science
Antibody Science
Biospecimen Assays
Biopharmaceutical Development
Electron Microscopy
HPV Serology Operating Procedures
Human SARS-CoV-2 Serology Standard
Nanotechnology
Protein Science
Collaborations
Collaboration
Partnership Development Office
Partnership Mechanisms
Academic Partnerships
Tech Transfer & Licensing
Intellectual Property and Strategic Agreements
Vendors & Subcontractors
Become a Vendor
Business Opportunities
Contracts and Acquisitions
Small Businesses, Nonprofits & HBCUs
Careers
Job Opportunities
Application Process
Benefits
Diversity and Inclusion
Internships and Fellowships
About
Who We Are
Mission & Core Values
Community Outreach
People
Publications
History